Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

By Foxton Richard   Land John   Heales Simon  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 751-756

Springer Publishing Company

Access to resources Recommend Favorite

Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease

By Zhao Baolu  

Neurochemical Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 630-638

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of the Efficacy of Solutes from Extremophiles on Protein Aggregation in Cell Models of Huntington’s and Parkinson’s Diseases

By Jorge Carla   Ventura Rita   Maycock Christopher   Outeiro Tiago   Santos Helena   Costa Júlia  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 1005-1011

Springer Publishing Company

Access to resources Recommend Favorite

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

By Youdim M. B. H.   Fridkin M.   Zheng H.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1455-1471

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

By Li Chao   Guo Yuan   Xie Wenjie   Li Xingang   Janokovic Joseph   Le Weidong  

Neurochemical Research, Vol. 35, Iss. 10, 2010-10 ,pp. : 1546-1556

Springer Publishing Company

Access to resources Recommend Favorite